What Can I Expect? Late Effects of Breast Cancer Treatment - Komen Perspectives - Susan G. Komen®
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡ - Annals of Oncology
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab - ScienceDirect
Long-Term Side Effects of Cancer Treatment | Cancer.Net
Breast Cancer Treatment: Herceptin Shorter Duration
Trastuzumab — Mechanism of Action and Use in Clinical Practice | NEJM
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab | JACC: Heart Failure
HER2+ Early Breast Cancer | Herceptin® (trastuzumab)
Cancers | Free Full-Text | Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma | HTML
Trastuzumab — Mechanism of Action and Use in Clinical Practice | NEJM
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model | Scientific Reports
Trastuzumab (Herceptin) - Oncology Nurse Advisor
The mechanistic insights of the arrhythmogenic effect of trastuzumab - ScienceDirect
Management of cardiac side-effects. | Download Table
Trastuzumab and Cardiotoxicity | IntechOpen
Trastuzumab (Herceptin) | American Journal of Neuroradiology
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer - The Breast
Herceptin side effects: What they are and how to manage them
Targeted therapeutic options and future perspectives for HER2-positive breast cancer | Signal Transduction and Targeted Therapy
Herceptin: A Wonder Drug With a Frightening Side Effect
Pertuzumab in the treatment of HER2-positive breast cancer: an evidenc | CE
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab - ScienceDirect
Herceptin (Trastuzumab) Side Effects and Screening - YouTube
